PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-0.23
Both companies show losses. Martin Whitman would check if industry conditions create special situations.
No Data
No Data available this quarter, please select a different quarter.
0.98
P/B 1.25-1.5x CRN.AX's 0.74. Martin Whitman would scrutinize if premium reflects better growth prospects.
-2.05
Negative FCF while CRN.AX shows P/FCF of 50.98. Joel Greenblatt would examine cash flow improvement potential.
-3.98
Negative operating cash flow while CRN.AX shows P/OCF of 12.69. Joel Greenblatt would examine operational improvement potential.
0.98
Fair value ratio 1.25-1.5x CRN.AX's 0.74. Martin Whitman would scrutinize if premium reflects better prospects.
-108.81%
Both companies show losses. Martin Whitman would check for industry-wide issues.
-48.87%
Negative FCF while CRN.AX shows yield of 1.96%. Joel Greenblatt would examine cash flow improvement potential.